PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.78%
Revenue growth 1.25-1.5x MRVL's 4.85%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
10.01%
Gross profit growth similar to MRVL's 9.90%. Walter Schloss would assume both firms track common industry trends.
15.16%
Positive EBIT growth while MRVL is negative. John Neff might see a substantial edge in operational management.
14.13%
Positive operating income growth while MRVL is negative. John Neff might view this as a competitive edge in operations.
10.15%
Positive net income growth while MRVL is negative. John Neff might see a big relative performance advantage.
10.00%
Positive EPS growth while MRVL is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
9.63%
Positive diluted EPS growth while MRVL is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.11%
Slight or no buybacks while MRVL is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.21%
Diluted share reduction more than 1.5x MRVL's 0.61%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
0.10%
Dividend growth under 50% of MRVL's 1.76%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
14.65%
OCF growth at 50-75% of MRVL's 28.58%. Martin Whitman would question if the firm lags in monetizing sales effectively.
12.52%
FCF growth under 50% of MRVL's 50.23%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
65.88%
Positive 10Y revenue/share CAGR while MRVL is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
52.11%
Positive 5Y CAGR while MRVL is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
20.69%
Positive 3Y CAGR while MRVL is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
320.99%
Positive long-term OCF/share growth while MRVL is negative. John Neff would see a structural advantage in sustained cash generation.
115.68%
Below 50% of MRVL's 566.76%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
22.95%
3Y OCF/share CAGR under 50% of MRVL's 69.79%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
259.89%
Positive 10Y CAGR while MRVL is negative. John Neff might see a substantial advantage in bottom-line trajectory.
156.30%
5Y net income/share CAGR above 1.5x MRVL's 67.59%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
45.48%
Positive short-term CAGR while MRVL is negative. John Neff would see a clear advantage in near-term profit trajectory.
28.12%
Below 50% of MRVL's 66.40%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
21.70%
Below 50% of MRVL's 56.78%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
11.02%
Below 50% of MRVL's 61.24%. Michael Burry suspects a serious short-term disadvantage in building book value.
686.53%
Dividend/share CAGR of 686.53% while MRVL is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
168.06%
5Y dividend/share CAGR above 1.5x MRVL's 0.95%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
64.54%
3Y dividend/share CAGR above 1.5x MRVL's 1.48%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
0.44%
AR growth is negative/stable vs. MRVL's 3.15%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-1.80%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
4.91%
Positive asset growth while MRVL is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
9.59%
Positive BV/share change while MRVL is negative. John Neff sees a clear edge over a competitor losing equity.
0.02%
Debt shrinking faster vs. MRVL's 0.06%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
1.30%
We increase R&D while MRVL cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
No Data
No Data available this quarter, please select a different quarter.